Contrary to clinical trial results, the survival benefit of checkpoint inhibitors in the real-world setting is lower among older people with NSCLC, who make up a large proportion of patients.
Lack of guideline-concordant treatment for early-stage non-small cell lung cancer common healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.